CLARA D. BLOOMFIELD, M.D.; RICHARD D. BRUNNING, M.D.
This content is PDF only. Please click on the PDF icon to access.
The French-American-British (FAB) leukemia cooperative study group, in this issue (1), adds another category of acute nonlymphocytic leukemia to their classification: acute leukemia of megakaryocyte lineage, or M7. As with prior FAB categories, M7 defines a type of leukemia that has been recognized for many years (2). Recently, as a result of developments in ultrastructural cytochemistry and immunologic phenotyping, acute leukemias of megakaryocytic lineage have been diagnosed increasingly (3-13); at least one group has reported that this type accounts for more than 10% of acute nonlymphocytic leukemias (10). Although a distinct clinical syndrome has not been delineated, it has been
BLOOMFIELD CD, BRUNNING RD. FAB M7: Acute Megakaryoblastic Leukemia—Beyond Morphology. Ann Intern Med. 1985;103:450–452. doi: 10.7326/0003-4819-103-3-450
Download citation file:
Published: Ann Intern Med. 1985;103(3):450-452.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use